A large Yale-led study of nearly 25 million privately insured adults found declining use of colonoscopy and FIT tests and rising adoption of stool DNA screening between 2017 and 2024. Despite universal insurance coverage, disparities emerged: men favored colonoscopy, women more often chose stool DNA tests, and higher socioeconomic or metropolitan areas had greater screening uptake. Researchers say the findings reveal an evolving, uneven screening landscape — and call for tailored interventions to reach the national 80% screening goal.
Keep Reading
Add A Comment